> Drug design: Using Mythos 5, our internal protein design experts accelerated... Nine of the 14 protein targets from this study (shown below) yielded strong candidates for *drug design that we’re currently investigating*.
(emphasis mine)
> queries that are beneficial in the hands of cybersecurity professionals and biology researchers could be dangerous if available to malicious actors... When Fable’s classifiers detect a request related to cybersecurity, *biology and chemistry*, or distillation, the response is automatically handled by Claude Opus 4.8 instead.
All of the things they are nerfing are things that they also intend to profit from themselves.
- Cybersecurity - selling this to companies and US gov through "Glass Wing".
- Selling inference (distillation risk).
- And now, drug design.
I'm extrapolating "currently investigating" to "are going to monetize" but I don't think that's a big stretch. They appear to be using safety as a cover for anti-competitive behaviour.
> Drug design: Using Mythos 5, our internal protein design experts accelerated... Nine of the 14 protein targets from this study (shown below) yielded strong candidates for *drug design that we’re currently investigating*.
(emphasis mine)
> queries that are beneficial in the hands of cybersecurity professionals and biology researchers could be dangerous if available to malicious actors... When Fable’s classifiers detect a request related to cybersecurity, *biology and chemistry*, or distillation, the response is automatically handled by Claude Opus 4.8 instead.
All of the things they are nerfing are things that they also intend to profit from themselves.
- Cybersecurity - selling this to companies and US gov through "Glass Wing".
- Selling inference (distillation risk).
- And now, drug design.
I'm extrapolating "currently investigating" to "are going to monetize" but I don't think that's a big stretch. They appear to be using safety as a cover for anti-competitive behaviour.